Clinical Trials Logo

Clinical Trial Summary

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.


Clinical Trial Description

The specific objectives are: 1. To determine the fungal species causing invasive fungal infection in different parts of the world. 2. To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis. 3. To describe the therapeutic regimens used and their efficacy. 4. To share clinical isolates among the contributors of Fungiscope. 5. To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01731353
Study type Observational
Source University of Cologne
Contact Oliver A Cornely, Prof.
Phone +49 221 478
Email oliver.cornely@uk-koeln.de
Status Recruiting
Phase
Start date March 2003
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05116059 - To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD
Completed NCT01916057 - Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis N/A
Completed NCT03262584 - Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Recruiting NCT04368559 - Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation Phase 3
Not yet recruiting NCT06285188 - Immunomonitoring of Mold Invasive Infections
Recruiting NCT05569824 - LFD of Aspergillus Antigen in Paediatrics
Completed NCT03577509 - Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China Phase 1
Recruiting NCT03774316 - De-escalation - Antifungal Treatment Immunocompromised Patients
Recruiting NCT05630976 - Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi Phase 4
Not yet recruiting NCT06376201 - A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease Phase 4
Completed NCT01259713 - Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia Phase 3
Recruiting NCT01135589 - Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation Phase 4